SCHEMBL30707261

SCHEMBL30707261

CCOC(=O)C(CC1CO1)C(=O)OCC

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
LMNA P02545 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TDP1 Q9NUW8 2/20 0.35
HSD17B10 Q99714 1/20 0.34
ALOX15 P16050 1/20 0.33
MEN1 O00255 1/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
SOAT1 P35610 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9510197 0.91 ALDH1A1 (0.40) ALDH1A1TP53CYP3A4LMNAKMT2A
SCHEMBL9515535 0.85 ALDH1A1 (0.41) ALDH1A1CYP3A4LMNAKMT2AMAPT
SCHEMBL11531232 0.80 LMNA (0.45) ALDH1A1TP53LMNAKMT2AMAPT
SCHEMBL20543639 0.80 ALDH1A1 (0.39) ALDH1A1CYP3A4LMNAKMT2AMAPT
SCHEMBL27510653 0.76 ALDH1A1 (0.51) ALDH1A1TP53CYP3A4
SCHEMBL25075052 0.76 ALDH1A1 (0.37) ALDH1A1CYP3A4LMNAKMT2AMAPT
SCHEMBL28049939 0.75 CA2 (0.42) ALDH1A1
SCHEMBL18095081 0.75 SMN1; SMN2 (0.47) ALDH1A1TP53CYP3A4LMNAKMT2A
SCHEMBL24894079 0.75 ALDH1A1 (0.30) ALDH1A1LMNAKMT2AMAPTHPGD
SCHEMBL9219750 0.75 L3MBTL1 (0.41) ALDH1A1LMNAKMT2AL3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4540255-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2025-04-23 EP disclosed
CN-119677749-A Azaquinazoline pan KRAS inhibitors 米拉蒂治疗股份有限公司 2025-03-21 CN disclosed
WO-2023244615-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2023-12-21 WO disclosed